TAS2R19

gene
On this page

Also known as T2R19T2R23

Summary

TAS2R19 (taste 2 receptor member 19, HGNC:19108) is a protein-coding gene on chromosome 12p13.2, encoding Taste receptor type 2 member 19 (P59542). Receptor that may play a role in the perception of bitterness and is gustducin-linked.

Predicted to enable G protein-coupled receptor activity and bitter taste receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway and detection of chemical stimulus involved in sensory perception of bitter taste. Located in membrane.

Source: NCBI Gene 259294 — RefSeq curated summary.

At a glance

  • Druggable target: yes — 1 molecules with ChEMBL bioactivity
  • MANE Select transcript: NM_176888

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:19108
Approved symbolTAS2R19
Nametaste 2 receptor member 19
Location12p13.2
Locus typegene with protein product
StatusApproved
AliasesT2R19, T2R23
Ensembl geneENSG00000212124
Ensembl biotypeprotein_coding
OMIM613961
Entrez259294

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000390673

RefSeq mRNA: 1 — MANE Select: NM_176888 NM_176888

CCDS: CCDS8640

Canonical transcript exons

ENST00000390673 — 1 exons

ExonStartEnd
ENSE000015085911102161911022620

Expression profiles

Bgee: expression breadth ubiquitous, 130 present calls, max score 87.66.

Top tissues by expression

132 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.66gold quality
adrenal tissueUBERON:001830375.72gold quality
corpus callosumUBERON:000233669.89gold quality
calcaneal tendonUBERON:000370166.66gold quality
colonic epitheliumUBERON:000039764.19gold quality
tonsilUBERON:000237263.63gold quality
cortical plateUBERON:000534363.22gold quality
left ovaryUBERON:000211962.99gold quality
cerebellar cortexUBERON:000212962.40gold quality
cerebellar hemisphereUBERON:000224562.30gold quality
right hemisphere of cerebellumUBERON:001489062.26gold quality
cerebellumUBERON:000203762.21gold quality
ovaryUBERON:000099261.89gold quality
stromal cell of endometriumCL:000225561.50gold quality
gastrocnemiusUBERON:000138861.29gold quality
ganglionic eminenceUBERON:000402360.91gold quality
endometriumUBERON:000129560.87gold quality
ventricular zoneUBERON:000305360.36gold quality
right ovaryUBERON:000211860.15gold quality
muscle of legUBERON:000138359.94gold quality
skeletal muscle tissueUBERON:000113458.89gold quality
apex of heartUBERON:000209858.73gold quality
body of uterusUBERON:000985358.06gold quality
tibial nerveUBERON:000132357.96gold quality
pituitary glandUBERON:000000756.38gold quality
adenohypophysisUBERON:000219656.33gold quality
muscle tissueUBERON:000238555.91gold quality
bone marrow cellCL:000209255.81silver quality
right uterine tubeUBERON:000130255.72gold quality
uterine cervixUBERON:000000255.44gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-GEOD-124858no46.16
E-ANND-3no0.05

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • Polymorphism of TAS2R3, TAS2R5, TAS2R19, and TAS2R50 genes and bitter food intake frequency inelderly woman. (PMID:32227702)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusTas2r136ENSMUSG00000053217
mus_musculusTas2r120ENSMUSG00000059382
rattus_norvegicusTas2r120ENSRNOG00000021445
rattus_norvegicusTas2r136ENSRNOG00000029561

Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)

Protein

Protein identifiers

Taste receptor type 2 member 19P59542 (reviewed: P59542)

Alternative names: Taste receptor type 2 member 23, Taste receptor type 2 member 48

All UniProt accessions (1): P59542

UniProt curated annotations — full annotation on UniProt →

Function. Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5.

Subcellular location. Membrane.

Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells.

Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.

Similarity. Belongs to the G-protein coupled receptor T2R family.

RefSeq proteins (1): NP_795369* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007960TAS2RFamily

Pfam: PF05296

UniProt features (19 total): topological domain 8, transmembrane region 7, sequence variant 2, chain 1, glycosylation site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P59542-F184.800.39

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 161

Function

Pathways and Gene Ontology

Reactome pathways

6 pathways

IDPathway
R-HSA-418594G alpha (i) signalling events
R-HSA-420499Class C/3 (Metabotropic glutamate/pheromone receptors)
R-HSA-162582Signal Transduction
R-HSA-372790Signaling by GPCR
R-HSA-388396GPCR downstream signalling
R-HSA-500792GPCR ligand binding

MSigDB gene sets: 28 (showing top): GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE, HMGA1_TARGET_GENES, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY

GO Biological Process (3): sensory perception of taste (GO:0050909), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186)

GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), protein binding (GO:0005515), bitter taste receptor activity (GO:0033038)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-4 pathways:

CategoryPathways
Signaling by GPCR2
GPCR downstream signalling1
GPCR ligand binding1
Signal Transduction1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
sensory perception of chemical stimulus1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
G protein-coupled receptor activity1
signal transduction1
transmembrane signaling receptor activity1
G protein-coupled receptor signaling pathway1
binding1
detection of chemical stimulus involved in sensory perception of bitter taste1
taste receptor activity1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

268 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TAS2R19TAS1R3Q7RTX0507
TAS2R19PKD1L3Q7Z443447
TAS2R19TAS1R1Q7RTX1436
TAS2R19TAS1R2Q8TE23432
TAS2R19PKD2L1Q9P0L9430
TAS2R19GNAT3A8MTJ3399
TAS2R19OR13C5Q8NGS8396
TAS2R19SIL1Q9H173371
TAS2R19SLC23A1Q9UHI7371
TAS2R19CA6P23280370
TAS2R19CTNNA1P35221353
TAS2R19OR5M8Q8NGP6348
TAS2R19SCNN1DP51172348
TAS2R19OR8U1Q8NH10337
TAS2R19MATR3P43243306

IntAct

23 interactions, top by confidence:

ABTypeScore
LNPEPTAS2R19psi-mi:“MI:0915”(physical association)0.560
TAS2R19TYW1Bpsi-mi:“MI:0915”(physical association)0.560
TAS2R19LNPEPpsi-mi:“MI:0915”(physical association)0.560
PGRMC2TAS2R19psi-mi:“MI:0915”(physical association)0.560
PVRTAS2R19psi-mi:“MI:0915”(physical association)0.560
TAS2R19TMEM14Bpsi-mi:“MI:0915”(physical association)0.560
TAS2R19TMEM167Bpsi-mi:“MI:0915”(physical association)0.560
TAS2R19MMGT1psi-mi:“MI:0915”(physical association)0.560
TAS2R19STXBP3psi-mi:“MI:0914”(association)0.350
TAS2R19TYW1Bpsi-mi:“MI:0915”(physical association)0.000
TAS2R19PGRMC2psi-mi:“MI:0915”(physical association)0.000
TAS2R19PVRpsi-mi:“MI:0915”(physical association)0.000
TAS2R19TMEM14Bpsi-mi:“MI:0915”(physical association)0.000
TAS2R19TMEM167Bpsi-mi:“MI:0915”(physical association)0.000
TAS2R19MMGT1psi-mi:“MI:0915”(physical association)0.000

BioGRID (24): TAS2R19 (Two-hybrid), TAS2R19 (Two-hybrid), TAS2R19 (Two-hybrid), TAS2R19 (Two-hybrid), TAS2R19 (Two-hybrid), TMEM167B (Two-hybrid), TYW1B (Two-hybrid), ABCB1 (Affinity Capture-MS), ATP5F1 (Affinity Capture-MS), ATP5D (Affinity Capture-MS), SERINC1 (Affinity Capture-MS), TTYH3 (Affinity Capture-MS), PAG1 (Affinity Capture-MS), NDUFAF1 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS)

ESM2 similar proteins: P0DSN6, P0DTE0, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T2, Q645T3, Q645T4, Q645T6, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645Z2, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646B4, Q646B9, Q646C0, Q646C1, Q646C2, Q646C3, Q646E0, Q646E1, Q646E2, Q646E3

Diamond homologs: P0DSN6, P0DTE0, P59528, P59530, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T0, Q645T2, Q645T3, Q645T4, Q645T6, Q645T7, Q645U8, Q645V1, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645V8, Q645V9, Q645Z2, Q645Z5, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646A2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

312 predictions. Top by Δscore:

VariantEffectΔscore
12:11021631:C:Adonor_gain0.8500
12:11021690:CAAAA:Cacceptor_gain0.8500
12:11021695:C:CCacceptor_gain0.8000
12:11022415:C:CTdonor_gain0.8000
12:11022336:TCTAA:Tdonor_gain0.7900
12:11022064:T:Adonor_gain0.7800
12:11021692:AAAC:Aacceptor_loss0.7300
12:11021695:C:Aacceptor_loss0.7300
12:11021696:T:Gacceptor_loss0.7300
12:11021961:T:TCacceptor_gain0.7300
12:11022441:G:Cdonor_gain0.7200
12:11021693:AA:Aacceptor_gain0.7100
12:11021961:T:Cacceptor_gain0.7000
12:11021964:C:CTacceptor_gain0.6900
12:11022177:A:ACdonor_gain0.6900
12:11022173:CAGTA:Cdonor_gain0.6700
12:11022416:C:CTdonor_gain0.6500
12:11021694:ACT:Aacceptor_gain0.6300
12:11021692:AAA:Aacceptor_gain0.6200
12:11022033:G:Cdonor_gain0.6200
12:11022388:TG:Tdonor_gain0.6100
12:11022600:A:ACdonor_gain0.6100
12:11021957:A:Cacceptor_gain0.6000
12:11021965:A:Tacceptor_gain0.6000
12:11021691:AAAA:Aacceptor_gain0.5900
12:11021696:T:Aacceptor_gain0.5800
12:11022599:TAGTA:Tdonor_gain0.5800
12:11022600:AGTAA:Adonor_gain0.5800
12:11021892:G:Cdonor_gain0.5700
12:11021695:CTG:Cacceptor_gain0.5600

AlphaMissense

1951 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:11021999:G:CS191R0.776
12:11021999:G:TS191R0.776
12:11022001:T:GS191R0.776
12:11022521:A:CF17L0.773
12:11022521:A:TF17L0.773
12:11022523:A:GF17L0.773
12:11021870:G:CF234L0.760
12:11021870:G:TF234L0.760
12:11021872:A:GF234L0.760
12:11022008:A:CF188L0.744
12:11022008:A:TF188L0.744
12:11022010:A:GF188L0.744
12:11022494:G:CF26L0.708
12:11022494:G:TF26L0.708
12:11022496:A:GF26L0.708
12:11022269:G:CS101R0.665
12:11022269:G:TS101R0.665
12:11022271:T:GS101R0.665
12:11022287:G:CS95R0.643
12:11022287:G:TS95R0.643
12:11022289:T:GS95R0.643
12:11022290:G:CF94L0.642
12:11022290:G:TF94L0.642
12:11022292:A:GF94L0.642
12:11022263:G:CS103R0.620
12:11022263:G:TS103R0.620
12:11022265:T:GS103R0.620
12:11022394:A:GW60R0.618
12:11022394:A:TW60R0.618
12:11022233:G:CF113L0.609

dbSNP variants (sampled 300 via entrez): RS1001923227 (12:11023236 GAC>G), RS1002259670 (12:11023595 A>T), RS1005893780 (12:11021315 A>G), RS1006916764 (12:11024387 T>A,C), RS1007189691 (12:11024310 A>C,G), RS1007563222 (12:11024068 G>T), RS1009124829 (12:11022851 T>C,G), RS1013457880 (12:11023633 C>T), RS1013725261 (12:11023934 T>G), RS1015544513 (12:11023263 C>G,T), RS1016064892 (12:11021331 C>G,T), RS1017987159 (12:11024069 T>C), RS1018355891 (12:11024388 C>T), RS1018581249 (12:11022643 C>A,T), RS1021083679 (12:11024396 C>G)

Disease associations

OMIM: gene MIM:613961 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4523255 (SINGLE PROTEIN)

Molecules with ChEMBL bioactivity

1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).

MoleculeNamePhasePatents
CHEMBL434ISOPROTERENOL440,234

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Taste 2 receptors

ChEMBL bioactivities

1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
8.31EC504.9nMISOPROTERENOL

CTD chemical–gene interactions

9 total (human), top 9 by PubMed support.

ChemicalActions (top 5)PubMed papers
2-methyl-4-isothiazolin-3-onedecreases expression1
CGP 52608affects binding, increases reaction1
2-palmitoylglycerolincreases expression1
Sunitinibincreases expression1
Air Pollutantsaffects expression, increases abundance1
Benzo(a)pyrenedecreases methylation1
Ozoneaffects expression, increases abundance1
Aflatoxin B1decreases methylation1
Sodium Selenitedecreases expression1

ChEMBL screening assays

18 unique, capped per target: 18 functional

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4419022FunctionalAgonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R48 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assayMethods of identifying antagonists of the hTAS2R46 bitter taste receptor

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.